Markers Associated With Tumor Recurrence in Patients With Breast Cancer Achieving a Pathologic Complete Response After Neoadjuvant Chemotherapy

BACKGROUND: Patients who achieve a tumor pathologic complete response (pCR) after neoadjuvant chemotherapy (NAC) have better outcomes than patients with residual tumor. However, tumors still recur in the pCR patients. Therefore, we aim to explore factors associated with tumor recurrence in this pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Li-Yun, Wang, Kun, Chen, Hai-Lu, Shi, Yan-Xia, Zhang, Yuan-Qi, Lin, Hao-Yu, Liang, Yuan-Ke, Xiao, Ying-Sheng, Wu, Zhi-Yong, Yuan, Zhong-Yu, Qiu, Si-Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067275/
https://www.ncbi.nlm.nih.gov/pubmed/35515127
http://dx.doi.org/10.3389/fonc.2022.860475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067275/
https://www.ncbi.nlm.nih.gov/pubmed/35515127
http://dx.doi.org/10.3389/fonc.2022.860475

Ejemplares similares